Proehl, president and chief executive officer of Santarus. "Recently published independent clinical research indicates that episodes of nocturnal acid reflux are more frequent in the first half of the night when patients with GERD lie down to sleep.
In nexium 40 mg the acute healing part of the study, esomeprazole 40mg once-daily provides more effective healing of erosive esophagitis after 4 weeks - 80. 9% and 74. 5% respectively (p less than 0.

0001) and Nexium 40 mg faster symptom relief when compared to pantoprazole 40mg once-daily. (NASDAQ:SNTS), a specialty pharmaceutical company focused on therapies for gastrointestinal diseases and disorders, today announced that new clinical data were presented in a poster session at the Digestive Diseases Week (DDW) meeting on May 21, 2006. The results indicated that patients treated with ZEGERID nexium 40 mg experienced significantly fewer episodes of nocturnal acid breakthrough (NAB) than with the comparator drugs, and that dosing ZEGERID at bedtime on an empty stomach provided more rapid control of gastric acid in the first half of the night, a critical period for acid control.

The NDA was submitted nexium 40 mg under the terms of a license agreement with Santarus. Furthermore, healing rates were higher from mild to severe grades of erosive esophagitis thus offering better treatment to patients across the spectrum of the disease. Esomeprazole (Nexium(R) 40 mg) nexium 40 mg provides greater gastric acid suppression compared with other PPIs, including omeprazole, lansoprazole, pantoprazole and rabeprazole - as reported in new research, released today at the US Digestive Disease Week in Orlando, Florida. Sun Pharmaceutical said the FDA nexium 40 mg has approved the company's abbreviated NDA to market its generic version of Hoffman la Roche's Demadex tablets indicated for treatment of edema associated with congestive heart failure, renal or hepatic disease. Nexium is approved in 10 mg or 20 mg daily for children 1-11 years old and 20 mg or 40 mg for patients 12-17. AstraZeneca is listed in the Dow Jones Sustainability Index (Global and European) as well as the FTSE4Good Index. A multinational survey of activities of daily living and GERD in clinical practice: is prescription therapy adequate? Presented at the Digestive Disease Week, Orlando, Florida, 20 May 2003, abstract 102115. References: (1)Miner P et al. Additional endpoints of the clinical study were the percentage of time gastric pH was greater than 4 and median gastric pH, which were evaluated in cumulative two-hour intervals during the nighttime hours. This means that 50 percent more patients experienced nighttime acid breakthrough with either Nexium or Prevacid than with ZEGERID. 2000;14:1249-1258. SAN DIEGO -- nexium 40 mg santarus, Inc. Ranbaxy believes that it has a first-to-file status on the drug, providing it Nexium 40 mg with a potential 180 days marketing exclusivity. It is nexium 40 mg a successor drug to Prilosec, whose patent protection expired in 2001.
He went on to say In previous comparative studies, Nexium(R) has been shown to provide more effective healing of erosive esophagitis and faster symptom control vs omeprazole and lansoprazole - this combined with the new EXPO data demonstrates the nexium 40 mg clear clinical benefits attributed to the more effective acid control profile of Nexium(R) vs other PPIs. Results from this head to head randomised, international multicentre, double-blind study reveal that patients treated with esomeprazole achieved significantly higher healing rates and experienced sustained resolution of heartburn throughout the 4 weeks treatment.